TREVI THERAPEUTICS INC (TRVI)
US89532M1018 - Common Stock
| TTM (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -44.32M | -29.07M | -29.15M | -33.94M | -32.76M | |||
| Depreciation Amortization | 142.00K | 123.00K | 40.00K | 50.00K | 50.00K | |||
| Change In Working Capital | 6.55M | -3.85M | -1.23M | 1.51M | 1.06M | |||
| Interest Paid | N/A | 331.00K | 590.00K | 600.00K | 180.00K | |||
| Taxes Paid | N/A | N/A | N/A | N/A | N/A | |||
| Other non cash items | 2.55M | 1.08M | 2.17M | 3.44M | 2.65M | |||
| OPERATING CASH FLOW | -35.07M | -31.71M | -28.18M | -28.95M | -29.00M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -45.00K | -137.00K | -160.00K | 0.00 | -30.00K | |||
| Other Investing Activity | 15.24M | 59.56M | -107.21M | N/A | N/A | |||
| INVESTING CASH FLOW | 15.19M | 59.43M | -107.37M | 0.00 | -30.00K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -129.00K | -9.50M | -5.83M | 0.00 | 14.00M | |||
| Stock Issued/Repurchased | 385.00K | 74.00K | 117.33M | 13.68M | 30.00K | |||
| Other Financing Activity | 9.71M | 1.52M | -190.00K | 7.09M | 2.69M | |||
| FINANCING CASH FLOW | 9.97M | -7.91M | 111.31M | 20.78M | 16.72M | |||
| CHANGE IN CASH | -9.91M | 19.81M | -24.24M | -8.17M | -12.31M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -35.07M | -31.71M | -28.18M | -28.95M | -29.00M | |||
| Capital Expenditure | -45.00K | -137.00K | -160.00K | 0.00 | -30.00K | |||
| FREE CASH FLOW | -35.11M | -31.85M | -28.34M | -28.95M | -29.03M | |||
All data in USD